Héctor Arreola-Ornelas, L. García-Mollinedo, A. Rosado-Buzzo, Javier Dorantes-Aguilar, E. Muciño-Ortega, J. Mould-Quevedo
{"title":"dalteparin在墨西哥成人医疗和外科患者相关静脉血栓栓塞疾病(vte)预防和管理中的成本效益","authors":"Héctor Arreola-Ornelas, L. García-Mollinedo, A. Rosado-Buzzo, Javier Dorantes-Aguilar, E. Muciño-Ortega, J. Mould-Quevedo","doi":"10.1007/BF03321481","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"29 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Coste-efectividad de dalteparina en la profilaxis y manejo de la enfermedad tromboembólica venosa (ETV) asociada al paciente adulto médico y quirúrgico en México\",\"authors\":\"Héctor Arreola-Ornelas, L. García-Mollinedo, A. Rosado-Buzzo, Javier Dorantes-Aguilar, E. Muciño-Ortega, J. Mould-Quevedo\",\"doi\":\"10.1007/BF03321481\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":101511,\"journal\":{\"name\":\"PharmacoEconomics Spanish Research Articles\",\"volume\":\"29 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PharmacoEconomics Spanish Research Articles\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/BF03321481\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Spanish Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03321481","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Coste-efectividad de dalteparina en la profilaxis y manejo de la enfermedad tromboembólica venosa (ETV) asociada al paciente adulto médico y quirúrgico en México